Press Releases
Click a headline below to view the item in a new window.
AspenBio Pharma Initiates Stock Buyback Plan »
April 25, 2008
AspenBio Pharma Advances AppyScore Towards Clinical Trials with Improved Specificity for Detecting Human Appendicitis »
April 23, 2008
AspenBio Pharma Enters Worldwide License Agreement for Bovine Reproduction Drugs »
April 7, 2008
AspenBio Pharma Appoints Dr. Mark Ratain to Board of Directors »
March 31, 2008
AspenBio Pharma to Present at the Roth Capital Partners 20th Annual Growth Stock Conference »
February 14, 2008
2007
AspenBio Pharma Closes $18.2 Million Private Placement of Common Stock »
December 24, 2007
AspenBio Pharma Announces $18 Million Private Placement of Common Stock »
December 20, 2007
AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference »
October 5, 2007
AspenBio Pharma to Present at the Edgewater Research Investor Conference »
October 4, 2007
AspenBio Pharma Reports Strong Results with Appendicitis Triage Blood Test from Large Multiple Hospital Study »
September 28, 2007
AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference »
August 29, 2007
AspenBio Pharma Shares Commence Trading on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' »
August 28, 2007
AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol 'APPY' »
August 21, 2007
AspenBio Pharma Reports Second Quarter 2007 Results »
August 20, 2007
AspenBio Pharma to Present at the August Noble Financial Conference »
August 13, 2007
AspenBio Pharma Advances BoviPure FSH™ Reproduction Drug with FDA Filing and GMP Manufacturing Contract »
July 27, 2007
AspenBio Pharma Reports First Quarter 2007 Results »
May 17, 2007
AspenBio Pharma Completes $9.3 Million Warrant Conversion »
May 8, 2007
AspenBio Pharma Corporate Profile »
April 6, 2007
AspenBio Pharma to Present at the Big Dog II Small Cap Conference »
April 2, 2007
AspenBio Pharma’s New Human Appendicitis Blood Test Continues to Show High Accuracy in Clinical Trials »
February 22, 2007
AspenBio Pharma to Present at the Roth Capital Partners 19th Annual Conference »
February 1, 2007
AspenBio Pharma’s Human Appendicitis Blood Test Shows Strong Preliminary Results as Clinical Diagnostic Aid »
January 16, 2007
AspenBio Pharma Investors Pay $2,078,000 in Cash Upon Exercise of Warrants »
January 4, 2007
AspenBio Pharma Files for FDA approval of BoviPure LH™ »
January 3, 2007
2006
AspenBio Pharma Reports Third Quarter 2006 Results »
November 17, 2006
AspenBio Pharma, Inc. to present at Paulson Investment's 29th Annual Westergaard SmallCap Conference to Showcase Emerging Industry Leaders »
October 11, 2006
New AspenBio Customer Places $600,000 Order »
October 3, 2006
AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference »
August 24, 2006
AspenBio Pharma Reports Second Quarter 2006 Results »
August 16, 2006
AspenBio Pharma, Inc. Announces Completion of $2.2 Million Private Placement and Additions to Scientific Staff »
May 9, 2006 / PR News
AspenBio Pharma Announces Successful Resolution of Hurst Litigation »
April 18, 2006
AspenBio Pharma, Inc. Announces Closing on $1,428,000 Private Placement »
April 13, 2006 / PR News
AspenBio Pharma Announces Year End Results and Sales Increase »
March 23, 2006
AspenBio Pharma Announces Recent Developments Regarding Human Appendicitis Test »
February 15, 2006 / PRNewswire-FirstCall
AspenBio Pharma Invited to Present at Roth Capital Partners' Annual Growth Stock Conference »
January 23, 2006
2005
AspenBio Pharma Engages Comprehensive Investor Relations Firm »
December 14, 2005 / PRNewswire-FirstCall
AspenBio Announces Product Development Status Update and Name Change »
November 29, 2005
AspenBio, Inc. Announces Completion of $3,557,892 Private Placement »
July 12, 2005
AspenBio Announces Significant Product Development Progress and Official Filing With FDA »
March 29, 2005
AspenBio Hires Richard Donnelly as President and CEO and Appointed as Board Member »
January 25, 2005
2004
AspenBio Appoints David Welch to the Board of Directors »
October 4, 2004
AspenBio Creates Scientific Advisory Board - Including Prominent PhD's and MD to Assist in Product Development »
September 7, 2004
AspenBio, Inc. Announces Completion of $2,535,000 Private Placement »
September 3, 2004 / PR News
AspenBio Signs Exclusive License with Washington University for Reproductive Patent Estate for Use in Animal Health »
May 21, 2004
